查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363168

上游生物加工市場規模、佔有率、趨勢分析報告：按產品、工作流程、使用類型、模式、地區和細分市場進行預測，2023-2030 年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type (Multi-Use, Single-Use), By Mode, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

上游生物加工市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2023年至2030年全球上游生物加工市場規模將以16.6%的年複合成長率成長，2030年達到591億美元。

生物製藥的商業性成功和廣泛接受為一些自家公司和合約製造生物製藥公司提供了一條利潤豐厚的成長道路。此外，對生物相似藥和生技藥品的高需求、推出具有成本效益的改進技術以及拋棄式系統的接受度提高等要素正在共同推動市場收益。

新興企業和新參與企業在新安裝的生物製造工廠時經常面臨預算限制。因此，這些營業單位正在透過將製造流程委託給合約服務來擴大其生物治療產品組合，有助於增加上游生物加工服務的收益。

連續的上游生物加工為生物加工產業帶來了顯著的效益。對於生物反應器培養物的澄清，擴大引入聲波技術和連續離心等方法，這往往會最大限度地減少澄清的負擔。這導致更高的細胞培養密度和更有效率的上游工程。

細胞株生產力在蛋白質表現和克隆篩選方面的持續進步預計將在預測期內實現細胞培養產品最快的年複合成長率。細胞培養被認為是上游生物加工中最困難和關鍵的步驟，因此需要更多地關注技術複雜性，從而在上游生物加工市場中佔據最大佔有率。

多用途系統等要素在於，這些系統需要拋棄式投資，利用率高，可應用於更大容量的生物過程，並能準確維持pH和氧氣。然而，從傳統不銹鋼生物反應器到拋棄式生物反應器系統的範式轉變一直是拋棄式領域利潤豐厚成長的要素。

主要市場參與者正在採取新產品開發、互利合作夥伴關係、協議和地理擴張等策略性舉措，以加強其在市場上的影響力。例如，2019年2月，丹納赫公司達成協議，收購通用電氣生命科學公司的生物製藥業務。透過此次收購，丹納赫將 GE BioPharma 的細胞培養基、拋棄式技術、開發設備和消耗品添加到其現有產品組合中，擴大了其市場佔有率。

上游生物加工市場報告亮點

  • 生物反應器的高可用性以及主要參與者不斷推出拋棄式生物反應器正在為生物反應器領域要素顯著的收益佔有率。
  • 擁有內部生物製造能力的成熟生物製藥製造公司的存在導致了該領域最大的收益佔有率。
  • 由於 CMO 透過將拋棄式系統整合到工廠來增加投資和擴大製造能力，預計上游生物加工的外包模式將在預測期內實現最快的年複合成長率。
  • 由於生物技術的不斷創新和對生物製藥的日益偏好，北美在全球上游生物加工市場中佔據主導地位。此外，大量的內部生物製藥製造商和對美國生物製藥市場的大量投資也支持了成長。
  • 由於人們對可用於上游工作流程中進程內控制的快速分析方法的認知不斷增強，預計亞太地區在預測期內將實現最快的年複合成長率。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 上游生物加工市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 上游生物加工市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 上游生物製程：產品估算與趨勢分析

  • 上游生物加工市場：要點
  • 上游生物加工市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 生物反應器/發酵罐
    • 2018年至2030年生物反應器/發酵槽市場估計與預測
  • 細胞培養產品
    • 2018年至2030年細胞培養產品市場估計與預測
  • 篩選
    • 過濾 2018 年至 2030 年市場估計與預測
  • 生物反應器配件
    • 2018年至2030年生物反應器配件市場估計與預測
  • 袋子/容器
    • 2018年至2030年袋子和容器市場估計和預測
  • 其他
    • 2018 年至 2030 年其他市場估計與預測

第5章 上游生物製程：工作流程估計與趨勢分析

  • 上游生物加工市場：要點
  • 上游生物加工市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 媒體準備
  • 細胞培養
  • 細胞分離

第6章 上游生物製程：使用類型估計與趨勢分析

  • 上游生物加工市場：要點
  • 上游生物加工市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 用途的
    • 2018年至2030年用途市場估計與預測
  • 一次使用
    • 2018年至2030年拋棄式市場估計與預測

第7章 上游生物過程：模式估計/趨勢分析

  • 上游生物加工市場：要點
  • 上游生物加工市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 公司內部
  • 委託

第8章 上游生物製程市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的上游生物加工市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • GE HealthCare
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Corning, Inc.
    • Sartorius AG
    • Eppendorf AG
    • Danaher
    • Boehringer Ingelheim GmbH
    • Applikon Biotechnology
    • PBS Biotech, Inc.
    • Lonza
    • CellGenix GmbH
    • Samsung BioLogics
    • AGC Inc.
    • VWR International, LLC
Product Code: GVR-3-68038-592-2

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.1 billion by 2030, expanding at a CAGR of 16.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Workflow
    • 1.1.3. Use Type
    • 1.1.4. Mode
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Workflow outlook
    • 2.2.3. Use type outlook
    • 2.2.4. Mode outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Upstream Bioprocessing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing: Product Estimates & Trend Analysis

  • 4.1. Upstream Bioprocessing Market: Key Takeaways
  • 4.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bioreactors/Fermenters
    • 4.3.1. Bioreactors/Fermenters market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Cell Culture Products
    • 4.4.1. Cell culture products market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Filters
    • 4.5.1. Filters market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Bioreactors Accessories
    • 4.6.1. Bioreactors accessories market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.7. Bags & Containers
    • 4.7.1. Bags & containers market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Upstream Bioprocessing: Workflow Estimates & Trend Analysis

  • 5.1. Upstream Bioprocessing Market: Key Takeaways
  • 5.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Media Preparation
    • 5.3.1. Media preparation market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.4. Cell Culture
    • 5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 5.5. Cell Separation
    • 5.5.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Upstream Bioprocessing: Use Type Estimates & Trend Analysis

  • 6.1. Upstream Bioprocessing Market: Key Takeaways
  • 6.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Multi-Use
    • 6.3.1. Multi-use market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 6.4. Single-Use
    • 6.4.1. Single-use market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 7. Upstream Bioprocessing: Mode Estimates & Trend Analysis

  • 7.1. Upstream Bioprocessing Market: Key Takeaways
  • 7.2. Upstream Bioprocessing Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. In-House
    • 7.3.1. In-house market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 7.4. Outsourced
    • 7.4.1. Outsourced market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Upstream Bioprocessing Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. GE HealthCare
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Thermo Fisher Scientific Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Merck KGaA
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Corning, Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Sartorius AG
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Eppendorf AG
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Danaher
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Boehringer Ingelheim GmbH
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Applikon Biotechnology
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. PBS Biotech, Inc.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Lonza
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. CellGenix GmbH
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Samsung BioLogics
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. AGC Inc.
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Product benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. VWR International, LLC
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Product benchmarking
      • 9.2.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 3 North America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 4 North America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 5 North America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 6 North America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 7 U.S. upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 8 U.S. upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 9 U.S. upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 10 U.S. upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 11 Canada upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 12 Canada upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 13 Canada upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 14 Canada upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 15 Europe upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 16 Europe upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 17 Europe upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 18 Europe upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 19 Europe upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 20 Germany upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 21 Germany upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 22 Germany upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 23 Germany upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 24 UK upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 25 UK upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 26 UK upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 27 UK upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 28 France upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 29 France upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 30 France upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 31 France upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 32 Italy upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 33 Italy upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 34 Italy upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 35 Italy upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 36 Spain upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 37 Spain upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 38 Spain upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 39 Spain upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 40 Sweden upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 41 Sweden upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 42 Sweden upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 43 Sweden upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 44 Norway upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 45 Norway upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 46 Norway upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 47 Norway upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 48 Denmark upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 49 Denmark upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 50 Denmark upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 51 Denmark upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 54 Asia Pacific upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 55 Asia Pacific upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 56 Asia Pacific upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 57 Japan upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 58 Japan upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 59 Japan upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 60 Japan upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 61 China upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 62 China upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 63 China upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 64 China upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 65 India upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 66 India upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 67 India upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 68 India upstream bioprocessing market, by mode (USD Billion) 2018 - 2030
  • Table 69 Australia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 70 Australia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 71 Australia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 72 Australia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 73 Thailand upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 74 Thailand upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 75 Thailand upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 76 Thailand upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 77 South Korea upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 78 South Korea upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 79 South Korea upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 80 South Korea upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 81 Latin America upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 82 Latin America upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 83 Latin America upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 84 Latin America upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 85 Latin America upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 86 Brazil upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 87 Brazil upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 88 Brazil upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 89 Brazil upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 90 Mexico upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 91 Mexico upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 92 Mexico upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 93 Mexico upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 94 Argentina upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 95 Argentina upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 96 Argentina upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 97 Argentina upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 98 Middle East and Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 99 Middle East and Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 100 Middle East and Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 101 Middle East and Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 102 Middle East and Africa upstream bioprocessing market, by region 2018 - 2030 (USD Billion)
  • Table 103 South Africa upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 104 South Africa upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 105 South Africa upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 106 South Africa upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 107 Saudi Arabia upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 108 Saudi Arabia upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 109 Saudi Arabia upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 110 Saudi Arabia upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 111 UAE upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 112 UAE upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 113 UAE upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 114 UAE upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)
  • Table 115 Kuwait upstream bioprocessing market, by product 2018 - 2030 (USD Billion)
  • Table 116 Kuwait upstream bioprocessing market, by workflow 2018 - 2030 (USD Billion)
  • Table 117 Kuwait upstream bioprocessing market, by use type 2018 - 2030 (USD Billion)
  • Table 118 Kuwait upstream bioprocessing market, by mode 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Upstream bioprocessing: Market outlook
  • Fig. 8 Upstream bioprocessing: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Upstream bioprocessing market driver impact
  • Fig. 14 Upstream bioprocessing market restraint impact
  • Fig. 15 Upstream bioprocessing market strategic initiatives analysis
  • Fig. 16 Upstream bioprocessing market: Product movement analysis
  • Fig. 17 Upstream bioprocessing market: Product outlook and key takeaways
  • Fig. 18 Bioreactors/Fermenters market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Cell culture products market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Filters market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Bioreactors accessories market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Bags & containers market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Upstream bioprocessing market: Workflow movement analysis
  • Fig. 25 Upstream bioprocessing market: Workflow outlook and key takeaways
  • Fig. 26 Media preparation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Cell culture market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Cell separation market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Upstream bioprocessing market: Use type movement analysis (USD Billion)
  • Fig. 30 Upstream bioprocessing market: Use type outlook and key takeaways
  • Fig. 31 Multi-use market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Single-use market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Upstream bioprocessing market: Mode movement analysis
  • Fig. 34 Upstream bioprocessing market: Mode outlook and key takeaways
  • Fig. 35 In-house market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Outsourced market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Global upstream bioprocessing market: Regional movement analysis
  • Fig. 38 Global upstream bioprocessing market: Regional outlook and key takeaways
  • Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)